Avalo Therapeutics, Inc. - AVTX

SEC FilingsOur AVTX Tweets

About Gravity Analytica

Recent News

  • 05.22.2026 - Avalo Therapeutics Announces Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4)
  • 05.13.2026 - Avalo Therapeutics Reports First Quarter 2026 Financial Results and Recent Business Updates

Recent Filings

  • 05.19.2026 - 4 Statement of changes in beneficial ownership of securities
  • 05.15.2026 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
  • 05.15.2026 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
  • 05.15.2026 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
  • 05.15.2026 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
  • 05.15.2026 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
  • 05.15.2026 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
  • 05.15.2026 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
  • 05.14.2026 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
  • 05.13.2026 - 10-Q Quarterly report [Sections 13 or 15(d)]